FDA Considers MDMA Therapy for PTSD Treatment
TL;DR Summary
The FDA is reviewing clinical trial data to decide on approving MDMA for PTSD treatment, despite concerns about study validity. President Biden plans to issue an executive order to address high asylum seeker numbers at the southern U.S. border, potentially invoking a section of the Immigration and Nationality Act to restrict immigration. In India, initial election results suggest Prime Minister Narendra Modi may win a third term, though his party has not achieved the super majority promised.
- Up First briefing: MDMA for PTSD treatment; Biden's border policy NPR
- Psychedelics Are Challenging the Scientific Gold Standard The Atlantic
- FDA advisers consider MDMA therapy to treat PTSD CNN
- Controversy Grows as FDA Panel Prepares to Review MDMA Drug Medscape
- The FDA is weighing whether to approve MDMA for PTSD. Here's what that could look like for patients. CBS News
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
5 min
vs 6 min read
Condensed
93%
1,030 → 77 words
Want the full story? Read the original article
Read on NPR